Entera Bio (ENTX) Tax Provisions (2021 - 2024)

Entera Bio has disclosed Tax Provisions across 4 years of filings, most recently posting $14000.0 for Q4 2024.

• Quarterly Tax Provisions changed N/A year-over-year to $14000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43000.0 (up 48.28% YoY) and the FY2024 annual result came in at $14000.0, down 51.72% from the prior year.
• Tax Provisions retreated to $14000.0 in Q4 2024, from $29000.0 in the prior quarter.
• Over five years, Tax Provisions peaked at $194000.0 in Q3 2022 and troughed at -$46000.0 in Q4 2022.
• A 4-year average of $12100.0 and a median of -$10000.0 in 2021 frame the typical range for Tax Provisions.
• Biggest YoY gain for Tax Provisions was 1592.31% in 2022; the steepest drop was 206.67% in 2022.
• Tracing ENTX's Tax Provisions over 4 years: stood at -$15000.0 in 2021, then tumbled by 206.67% to -$46000.0 in 2022, then jumped by 163.04% to $29000.0 in 2023, then plunged by 51.72% to $14000.0 in 2024.
• Business Quant data shows ENTX's Tax Provisions at $14000.0 in Q4 2024, $29000.0 in Q3 2023, and -$46000.0 in Q4 2022.